Effect of acetylcysteine on experimental corneal wounds in dogs

Ophthalmic Research

Volumn 35, Issue 6, 2003, Pages 319-323

  Aldavood, S J ^a,b   Behyar, R ^a   Sarchahi, A A ^a   Rad, M A ^a   Noroozian, I ^a   Ghamsari, S M ^a   Sadeghi Hashjin, G ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b NONE   (Iran)

Author keywords

Acetylcysteine; Corneal ulcers; Wound healing

Indexed keywords

ACETYLCYSTEINE; FLUORESCEIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA INJURY; DOG; DRUG EFFECT; EXPERIMENT; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; STAINING; STATISTICAL SIGNIFICANCE; STROMA; TIME; WOUND HEALING;

ACETYLCYSTEINE; ADMINISTRATION, TOPICAL; ANIMALS; CORNEA; CORNEAL ULCER; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FREE RADICAL SCAVENGERS; MALE; OPHTHALMIC SOLUTIONS; WOUND HEALING;

EID: 0348048842     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074070     Document Type: Article

References (26)

1. Ziment I: Acetylcysteine: A drug that is much more than a mucokinetic. Biomed Pharmacother 1988;513:520-542.
2. Webb WR: Clinical evaluation of a new mucolytic agent acetylcysteine. J Thorac Cardiovasc Surg 1962;44:330-335.
3. Sheffner AL: The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine. Ann NY Acad Sci 1963;106:299-304.
4. Absolon MJ, Brown CA: Acetylcysteine in kerato-conjunctivitis sicca. Br J Ophthalmol 1968;52:310-316.
5. Slansky HH, Berman MB, Dohlman CH, Rose J: Cysteine and acetylcysteine in the prevention of corneal ulcerations. Ann Ophthalmol 1970;2:488-493.
6. Haut J, Labrune P, Ullern M: New trial treatment of dry eye with acetylcysteine ophthalmic solution. Bull Soc Ophthalmol Fr 1977;77:165-167.
7. Brown SI, Weller CA: Collagenase inhibitors in prevention of ulcers alkali-burned cornea. Arch Ophthalmol 1970;83:352-353.
8. Brown SI, Tragakis M, Pearce D: Treatment of the alkali-burned cornea. Am J Ophthalmol 1972;74:316-320.
9. Williamson J, Doig WM, Forrester JV, Tham MH, Wilson T, Whaley K, Carsondick W: Management of the dry eye in Sjögren's syndrome. Br J Ophthalmol 1974;58:798-805.
10. Franke G, Wilhelm F, Deutschmann S, Pedal W: Experiences with a new corneal suction trephine. Acta Ophthalmol 1989;67:597-600.
11. Berman MB: Collagenase inhibitors: Rationale for their use in treating corneal ulceration. Int Ophthalmol Clin 1975;15:49-66.
12. Frauenfelder FT, Wright P, Tripathi RC: Corneal mucus plaques. Am J Ophthalmol 1977;83:191-197.
13. Marsh RJ, Cooper M: Ophthalmic zoster: Mucous plaque keratitis. Br J Ophthalmol 1987;71:725-728.
14. Obenberger J, Cejkova J: Corneal damage following intracorneal injection of N-acetyl-L-cysteine. Albrecht von Graefes Arch Klin Exp Ophthalmol 1972;285:171-176.
15. Petroutsos G, Guimaraes R, Giraud JP, Renard G, Pouliquen Y: Effect of acetylcysteine (Mucomyst) on epithelial wound healing. Ophthalmic Res 1982;14:241-248.
16. Sugar A, Waltman SR: Corneal toxicity of collagenase inhibitors. Invest Ophthalmol 1973;12:779-782.
17. Nichols BA, Chiappino L, Dawson CR: Demonstration of the mucous layer of the tear film by electron microscopy. Invest Ophthalmol Vis Sci 1985;26:464.
18. Draeger J, Hackelbusch R: Experimentelle Untersuchungen und klinische Ergebnisse mit neuen Rotorinstrumenten. Ophthalmologica, 1972;164:273-283.
19. Fitton JH, Ziegelaar BW, Hicks CR, Clayton AB, Crawford GJ, Constable IJ, Chirila TV: Assessment of anticollagenase treatments after insertion of a keratoprosthetic material in the rabbit cornea. Cornea 1998;17:108-114.
20. Brown SI, Akia S, Weller CA: Prevention of the ulcers of the alkali-burned cornea: Preliminary studies with collagenase inhibitors. Arch Ophthalmol 1969;82:95-97.
21. Berman M, Dohlman C: Collagenase inhibitors. Arch Ophthalmol Rev Gen Ophthalmol (Paris) 1975;35:95-112.
22. Berman M, Manable R: Corneal collagenases: Evidence for zinc metalloenzymes. Ann Ophthalmol 1973;5:1193-1195.
23. Kanao S, Kouzuki S, Isuneno M, Enomoto H, Yasuhiro K, Yamane Y: Clinical application of 3% N-acetylcysteine eye drops in corneal diseases in dogs. J Japan Vet Med Assoc 1993;46:488-491.
24. Burns FR, Stack MS, Gray RD, Paterson CA: Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci 1989;30:1569-1575.
25. Therms F, Molon-Noblot S, Grove J: Effects of acetylcysteine on rabbit conjunctival and corneal surfaces. Invest Ophthalmol Vis Sci 1991;32:2958-2963.
26. Chen HB, Yamabayashi S, Ou B, Tanaka Y, Ohno S, Tsukahara S: Structure and composition of rat precorneal tear film. A study by an in vivo cryofixation. Invest Ophthalmol Vis Sci 1977;38:381-387.